Peptides Lack Reliable Safety Information, Watchdog Warns BPC 157: The peptide with big claims and scant evidence STAT When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions Multifunctionality and Possible Medical Application of the BPC 157 PeptideLiterature and Patent Review The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and BREAKING NEWS: Peptides are coming In July, the FDA is reviewing BPC 157, TB 500, Semax, Epitalon and more. The meeting will be open to the public. The peptide era begins.